FindTrial
Sign In

Placebo: 0.9% normal saline

BIOLOGICAL2 trials

Sponsors

Sanofi Pasteur, a Sanofi Company

Conditions

Clostridium Difficile InfectionDiarrhea

Phase 2

Study of Different Formulations of a Clostridium Difficile Toxoid Vaccine Given at Three Different Schedules in Adults
CompletedNCT01230957
Sanofi Pasteur, a Sanofi CompanyClostridium Difficile Infection, Diarrhea
Start: 2010-10-31End: 2013-03-31Updated: 2018-07-18

Phase 3

Study of a Candidate Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection
TerminatedNCT01887912
Sanofi Pasteur, a Sanofi CompanyClostridium Difficile Infection
Start: 2013-07-30End: 2018-06-12Updated: 2022-03-28

Related Papers

Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial.
2020-09-1554 citations
On the use of nonparametric tests for comparing immunological Reverse Cumulative distribution curves (RCDCs).
2019-09-163 citations